Literature DB >> 33972243

A Pragmatic Machine Learning Model To Predict Carbapenem Resistance.

Ryan J McGuire1, Sean C Yu2, Philip R O Payne2, Albert M Lai2, M Cristina Vazquez-Guillamet3,4, Marin H Kollef3, Andrew P Michelson2,3.   

Abstract

Infection caused by carbapenem-resistant (CR) organisms is a rising problem in the United States. While the risk factors for antibiotic resistance are well known, there remains a large need for the early identification of antibiotic-resistant infections. Using machine learning (ML), we sought to develop a prediction model for carbapenem resistance. All patients >18 years of age admitted to a tertiary-care academic medical center between 1 January 2012 and 10 October 2017 with ≥1 bacterial culture were eligible for inclusion. All demographic, medication, vital sign, procedure, laboratory, and culture/sensitivity data were extracted from the electronic health record. Organisms were considered CR if a single isolate was reported as intermediate or resistant. Patients with CR and non-CR organisms were temporally matched to maintain the positive/negative case ratio. Extreme gradient boosting was used for model development. In total, 68,472 patients met inclusion criteria, with 1,088 patients identified as having CR organisms. Sixty-seven features were used for predictive modeling. The most important features were number of prior antibiotic days, recent central venous catheter placement, and inpatient surgery. After model training, the area under the receiver operating characteristic curve was 0.846. The sensitivity of the model was 30%, with a positive predictive value (PPV) of 30% and a negative predictive value of 99%. Using readily available clinical data, we were able to create a ML model capable of predicting CR infections at the time of culture collection with a high PPV.

Entities:  

Keywords:  antibiotic resistance; carbapenem; electronic health record; machine learning; predictive modeling

Mesh:

Substances:

Year:  2021        PMID: 33972243      PMCID: PMC8218615          DOI: 10.1128/AAC.00063-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  From Local Explanations to Global Understanding with Explainable AI for Trees.

Authors:  Scott M Lundberg; Gabriel Erion; Hugh Chen; Alex DeGrave; Jordan M Prutkin; Bala Nair; Ronit Katz; Jonathan Himmelfarb; Nisha Bansal; Su-In Lee
Journal:  Nat Mach Intell       Date:  2020-01-17

2.  Ascent of machine learning in medicine.

Authors: 
Journal:  Nat Mater       Date:  2019-05       Impact factor: 43.841

3.  Optimal turnaround time for direct identification of microorganisms by mass spectrometry in blood culture.

Authors:  Adrien Randazzo; Marc Simon; Pierre Goffinet; Jean-François Classen; Nicolas Hougardy; Pascal Pierre; Philippe Kinzinger; Etienne Mauel; Jean-Sébastien Goffinet
Journal:  J Microbiol Methods       Date:  2016-08-21       Impact factor: 2.363

4.  Escherichia coli: development of carbapenem resistance during therapy.

Authors:  Tao Hong; Ellen Smith Moland; Baha Abdalhamid; Nancy D Hanson; Jie Wang; Cindy Sloan; Diane Fabian; Awny Farajallah; Jerome Levine; Kenneth S Thomson
Journal:  Clin Infect Dis       Date:  2005-04-13       Impact factor: 9.079

5.  Risk factors and mortality in the Carbapenem-resistant Klebsiella pneumoniae infection: case control study.

Authors:  Fethiye Akgul; Ilkay Bozkurt; Mustafa Sunbul; Saban Esen; Hakan Leblebicioglu
Journal:  Pathog Glob Health       Date:  2016-12-01       Impact factor: 2.894

6.  The incremental cost of infections associated with multidrug-resistant organisms in the inpatient hospital setting-A national estimate.

Authors:  Kenton J Johnston; Kenneth E Thorpe; Jesse T Jacob; David J Murphy
Journal:  Health Serv Res       Date:  2019-03-12       Impact factor: 3.402

7.  Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.

Authors:  Mitchell J Schwaber; Shiri Klarfeld-Lidji; Shiri Navon-Venezia; David Schwartz; Azita Leavitt; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

8.  Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.

Authors:  Marya D Zilberberg; Brian H Nathanson; Kate Sulham; Weihong Fan; Andrew F Shorr
Journal:  BMC Infect Dis       Date:  2017-04-17       Impact factor: 3.090

9.  Risk Factors for Development of Carbapenem Resistance Among Gram-Negative Rods.

Authors:  Stefan E Richter; Loren Miller; Jack Needleman; Daniel Z Uslan; Douglas Bell; Karol Watson; Romney Humphries; James A McKinnell
Journal:  Open Forum Infect Dis       Date:  2019-01-23       Impact factor: 3.835

View more
  4 in total

Review 1.  Timing of antibiotic therapy in the ICU.

Authors:  Marin H Kollef; Andrew F Shorr; Matteo Bassetti; Jean-Francois Timsit; Scott T Micek; Andrew P Michelson; Jose Garnacho-Montero
Journal:  Crit Care       Date:  2021-10-15       Impact factor: 9.097

Review 2.  Treatment of Severe Infections Due to Metallo-Betalactamases Enterobacterales in Critically Ill Patients.

Authors:  Jean-François Timsit; Paul-Henri Wicky; Etienne de Montmollin
Journal:  Antibiotics (Basel)       Date:  2022-01-24

3.  Ceftriaxone resistance and adequacy of initial antibiotic therapy in community onset bacterial pneumonia.

Authors:  Richard F Van Besien; Nicholas Hampton; Scott T Micek; Marin H Kollef
Journal:  Medicine (Baltimore)       Date:  2022-05-20       Impact factor: 1.817

Review 4.  A Review of Converging Technologies in eHealth Pertaining to Artificial Intelligence.

Authors:  Iuliu Alexandru Pap; Stefan Oniga
Journal:  Int J Environ Res Public Health       Date:  2022-09-10       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.